8.460USDMkt Cap: 1.96B USDP/E: 12.44Last update: 2026-05-21
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internat…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap1.96B USD
Enterprise Value43.71B USD
Revenue (TTM)509.86M USD
Gross Profit292.76M USD
Net Income (TTM)146.93M USD
Revenue/Share2.143 USD
Last Price8.460 USD
Fiscal Year EndDec 2025
MR QuarterMar 2021
Employees640
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)12.44
P/E (Forward)8.01
PEG—
EV/EBITDA203.46
EV/Revenue85.73
P/S3.85
P/B5.04
EPS (TTM)0.68
EPS (Forward)1.06
52W Range
8.42520% of range8.600
52W High8.600 USD
52W Low8.425 USD
Profitability
Gross Margin57.39%
Oper. Margin-123.39%
EBITDA Margin42.13%
Profit Margin28.80%
ROE30.78%
ROA23.54%
Growth
Revenue Growth15.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.40M USD
CapEx (TTM)22.89M USD
FCF Margin11.45%
FCF Yield2.98%
Net Debt41.75B USD
Net Debt/EBITDA194.34
Balance Sheet
Debt/Equity0.17
Current Ratio6.95
Quick Ratio3.73
Book Value/Sh1.680 USD
Cash/Share241.28 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)16.75 USD
Target Range12.00 USD – 20.00 USD
# Analysts4
Ownership
Shares Out.231.77M
Float226.73M
Insiders1.86%
Institutions93.97%
Short Interest
Short Ratio3.5d
Short % Float10.87%
Short % Out.8.89%
Shares Short20.66M
Short (prev mo.)22.18M
Technical
SMA 5010.54 (-19.8%)
SMA 20015.18 (-44.3%)
Beta0.82
S&P 52W Chg28.31%
Avg Vol (30d)3.29M
Avg Vol (10d)5.26M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—